Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01298765 · ClinicalTrials.gov registry record · Phase 3
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
A Phase 3 study, sponsored by BioDelivery Sciences International.
- Completed
- Registry status
- Phase 3
- Development phase
- 302
- Enrollment target
NCT01298765: Completed Phase 3 study, sponsored by BioDelivery Sciences International.
NCT01298765 is a Phase 3 study that has completed, run by BioDelivery Sciences International. The registered enrollment target is 302 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01298765, a Phase 3 study, has completed, sponsored by BioDelivery Sciences International.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 302 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether BEMA Buprenorphine is safe in the treatment of chronic pain.
Primary Outcome
The NRS Pain intensity score is a segmented version of a visual analog scale used to measure pain. The scale is from 0 (no pain) to 10. Scores between greater than 0 and 3 are considered mild pain, scores from greater than 3 to 6 are moderate and greater than 6 to 10 are severe. The daily average is calculated and used to calculate the change from baseline at week 52.
Interventions
- DRUG BEMA Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
What the finished NCT01298765 record still lists
NCT01298765 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 1 intervention - of which BEMA Buprenorphine is the first listed.
NCT01298765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01298765 about?
NCT01298765 is a clinical study titled "Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain". The purpose of this study is to determine whether BEMA Buprenorphine is safe in the treatment of chronic pain.
What is the current status of trial NCT01298765?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 302 participants. The study started on 2011-03. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01298765?
The interventions under investigation include: BEMA Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT01298765?
This trial is sponsored by BioDelivery Sciences International, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01298765's enrollment target sits among peer trials
302 1119th of 2000 higher than 880 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia